Guangdong’s 2012 Drug Procurements Show Increased Quality Focus
This article was originally published in PharmAsia News
Executive Summary
Guangdong’s 2012 drug procurement policy will resemble its 2011 predecessor that set fixed prices for low-priced drugs and slightly raised price caps for drugs with higher production costs.